Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | HTR7 | P34969 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19301013 | 0.94 | CA2 (0.53) | CA2ALDH1A1LMNAPOLBNPSR1 | |
| SCHEMBL21135321 | 0.89 | CA2 (0.49) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL1514211 | 0.89 | CA2 (0.49) | CA2ALDH1A1LMNAPOLBNPSR1 | |
| SCHEMBL15455407 | 0.88 | ALDH1A1 (0.50) | CA2ALDH1A1LMNAPOLBTMEM97 | |
| SCHEMBL21135532 | 0.88 | CA2 (0.50) | CA2LMNAPOLB | |
| SCHEMBL9080283 | 0.88 | CA2 (0.50) | CA2LMNAPOLB | |
| SCHEMBL3685538 | 0.87 | CA2 (0.53) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL9106303 | 0.87 | CA2 (0.47) | CA2ALDH1A1LMNAPOLBNPSR1 | |
| SCHEMBL2297204 | 0.86 | CA2 (0.49) | CA2LMNAPOLB | |
| SCHEMBL3188329 | 0.84 | CA2 (0.50) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190194157-A1 | COALESCING AGENT DERIVED FROM DIOXOLANE DERIVATIVES | PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED (TH) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194157-A1 | COALESCING AGENT DERIVED FROM DIOXOLANE DERIVATIVES | ITCH, RNF168, DCTN1 | CA2 3668/4885TSHR 3672/4885ALDH1A1 1248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.